Pharmacology and Therapeutic Potential of the 5-HT7 Receptor

被引：35
|
作者：
Blattner, Kevin M. [1 ]
Canney, Daniel J. [1 ]
Pippin, Douglas A. [2 ]
Blass, Benjamin E. [1 ]
机构：
[1] Temple Univ, Sch Pharm, Dept Pharmaceut Sci, Moulder Ctr Drug Discovery Res, 3307 North Broad St, Philadelphia, PA 19140 USA
[2] Praeventix LLC, 665 Stockton Dr,Suite 200H, Exton, PA 19341 USA
来源：
ACS CHEMICAL NEUROSCIENCE | 2019年 / 10卷 / 01期
关键词：
Serotonin receptor; serotonin (5-HT); G-protein-coupled receptor (GPCR); 5-HT7; receptor; agonist; antagonist; PROTEIN-KINASE-A; EXTRACELLULAR-REGULATED KINASE; ANTEROVENTRAL PREOPTIC REGION; ANTIDEPRESSANT-LIKE BEHAVIOR; MULTIOBJECTIVE BASED DESIGN; PHRENIC MOTOR FACILITATION; DEPRESSIVE-LIKE BEHAVIORS; GENOME-WIDE ASSOCIATION; BETA-CASEIN EXPRESSION; EYE-MOVEMENT SLEEP;
D O I：
10.1021/acschemneuro.8b00283
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
It is well-documented that serotonin (5-HT) exerts its pharmacological effects through a series of 5-HT receptors. The most recently identified member of this family, 5-HT7, was first identified in 1993. Over the course of the last 25 years, this receptor has been the subject of intense investigation, and it has been demonstrated that 5-HT7 plays an important role in a wide range of pharmacological processes. As a result of these findings, modulation of 5-HT7 activity has been the focus of numerous drug discovery and development programs. This review provides an overview of the roles of 5-HT7 in normal physiology and the therapeutic potential of this interesting drug target.
引用
收藏
页码：89 / 119
页数：61
相关论文
共 50 条
  • [1] 5-HT7 receptors:: Pharmacology and potential therapeutic applications
    Hagan, JJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 : U49 - U49
  • [2] NEUROCHEMISTRY, PHARMACOLOGY AND LOCALIZATION OF THE 5-HT7 RECEPTOR
    BRANCHECK, TA
    ZGOMBICK, JM
    ADHAM, N
    BARD, J
    DURKIN, M
    GUSTAFSON, E
    WEINSHANK, RL
    JOURNAL OF NEUROCHEMISTRY, 1995, 65 : S205 - S205
  • [3] 5-HT7 receptor ligands:: Recent developments and potential therapeutic applications
    Pittala, Valeria
    Salerno, Loredana
    Modica, Maria
    Siracusa, Maria Angela
    Romeo, Giuseppe
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2007, 7 (09) : 945 - 960
  • [4] Therapeutic Potential of 5-HT7 Receptors in Mood Disorders
    Mnie-Filali, Ouissame
    Lambas-Senas, Laura
    Scarna, Helene
    Haddjeri, Nasser
    CURRENT DRUG TARGETS, 2009, 10 (11) : 1109 - 1117
  • [5] 5-HT7 receptor antagonist
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1998, 3 (06) : 296 - 296
  • [6] Genetic knockout and pharmacological blockade studies of the 5-HT7 receptor suggest therapeutic potential in depression
    Guscott, M
    Bristow, LJ
    Hadingham, K
    Rosahl, TW
    Beer, MS
    Stanton, JA
    Bromidge, F
    Owens, AP
    Huscroft, I
    Myers, J
    Rupniak, NM
    Patel, S
    Whiting, PJ
    Hutson, PH
    Fone, KC
    Biello, SM
    Kulagowski, J
    McAllister, G
    NEUROPHARMACOLOGY, 2005, 48 (04) : 492 - 502
  • [7] Cloning, expression and pharmacology of a truncated splice variant of the human 5-HT7 receptor
    Jasper, JR
    To, ZP
    Kosaka, A
    Eglen, RM
    Chang, DJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 : P298 - P298
  • [8] The 5-HT7 receptor in learning and memory
    Roberts, Amanda J.
    Hedlund, Peter B.
    HIPPOCAMPUS, 2012, 22 (04) : 762 - 771
  • [9] Synthesis of New Serotonin 5-HT7 Receptor Ligands. Determinants of 5-HT7/5-HT1A Receptor Selectivity
    Medina, Rocio A.
    Sallander, Jessica
    Benhamu, Bellinda
    Porras, Esther
    Campillo, Mercedes
    Pardo, Leonardo
    Lopez-Rodriguez, Maria L.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2384 - 2392
  • [10] Expression of the 5-HT7 receptor in schizophrenia
    East, SZ
    Burnet, PWJ
    Harrison, PJ
    SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 71 - 71
12345